Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novalac is a private French specialty infant nutrition company that develops and commercializes formula products focused on pediatric gastroenterology, allergology, and other infant feeding needs. The business operates through United Pharmaceuticals SAS and markets the Novalac brand in more than 60 countries across five continents. Its portfolio consists of commercial-stage infant and toddler formulas for common conditions such as reflux, colic, constipation, allergy, and general nutritional support. The company emphasizes clinically supported nutritional solutions and partners with pharmaceutical distributors and laboratories for international commercialization. Manufacturing is carried out in Europe, with product supply referenced in France and Germany.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novalac Nutrition & Health.